← Browse by Condition
Medical Condition

unresectable lung neuroendocrine neoplasm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04665739 Phase 2
Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →